CTYX Connectyx Technologies Holding

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies
EN
09/10/2020

Underlying

CTYXConnectyx Technologies Holding

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Connectyx Technologies Holding

 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology Announces Canadian Patent Allowance

Curative Biotechnology Announces Canadian Patent Allowance “Druggable Target to Treat Retinal Degeneration” Palm Beach Gardens, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the “Company”), a company developing metformin-based eye drops for the treatment of degenerative eye diseases, today announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for Canadian Patent Application No. 3,151,011, entitled “Druggable Target to Treat Retinal Degeneration.” Curative is the exclusive worldwide licensee of thi...

January 23, 2026 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Announces Letter to Shareholders

Curative Biotechnology, Inc. Announces Letter to Shareholders Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced the following update to shareholders. Dear fellow shareholders and interested investors, We are writing to provide an important update on our business strategy and operational path forward. The Company has been actively pursuing th...

November 18, 2025 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, In...

Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor Palm Beach Gardens, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the engagement of Golden Eagle Capital Advisors, Inc (“GECA”), a financial advisory group based in Dubai as the exclusive agent and strategic advisor to the company. About Golden Eagle Capital Advisors, Inc. GOLDEN EAGLE CAPITAL...

December 13, 2024 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah ...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah. Dr. Heah is expected to join its Board of Directors immediately as an independent director. In addition to other Board duties Dr. Heah will serve on the newly created Clinical Development Co...

March 22, 2024 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah ...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced its nomination to its Board of Directors of Dr. Theresa Heah. Dr. Heah is expected to join its Board of Directors as an indepe...

January 8, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch